Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
DORC Receives FDA Clearance for Eva Nexus System
DORC International has announced 510(k) market clearance and the launch of the Eva Nexus. According to DORC, the Eva Nexus features multiple innovations to improve performance, efficiency, and stability for retina surgeons, including Smart IOP for anterior and posterior chamber stability; DORC’s trocar cannula system with HI-FLOW infusion…
New Device Targets Dry Eye and Beyond with Thermal Imaging
A groundbreaking innovation in ocular health assessment is on the horizon, as a new University of Waterloo spinoff company, ThermOcular AI, unveils its pioneering approach to eye temperature monitoring. Transforming Ocular Diagnostics Founded by vision science and engineering researchers from…
Australia’s 2nd Generation Bionic Eye Shows Promise in RP
Australia’s second-generation bionic eye has demonstrated “substantial improvement” in functional vision, daily activities, and quality of life for four participants over a period of more than two and a half years, according to the results of the first clinical trial.…
What Is Lens Replacement Surgery?
Lens replacement surgery, also known as Refractive Lens Exchange (RLE) or Clear Lens Extraction (CLE), is a procedure designed to improve vision by replacing the eye’s natural lens with an artificial one. This surgery is particularly beneficial for those who…
Your Complete Guide to Cataract Surgery
Cataract surgery is a safe, effective procedure that improves vision by removing cloudy lenses from the eyes and replacing them with artificial lenses. As technology advances and techniques improve, understanding the nuances of cataract surgery is crucial for anyone considering…
Melt Pharmaceuticals Launches MELT-300 Phase 3 Program
Melt Pharmaceuticals has completed the dosing of its first patient in its phase 3 program for MELT-300, marking a crucial step in evaluating the safety and efficacy of this pioneering product. MELT-300 is a non-intravenous, non-opioid tablet comprising fixed doses…
Eversight Partners with LighTopTech to Improve Eye Imaging
Eversight has partnered up with LighTopTech to elevate the standards of imaging modalities for eye tissues. This ambitious partnership, spanning over four years, sets out to redefine the landscape of ocular imaging in both clinical and research domains. LighTopTech’s OCX…
BIOPHTA Secures €6.5M to Advance Eye Disease Therapy
BIOPHTA, a preclinical biotech company, has successfully closed a Seed round, raising €6.5 million to advance its pioneering technology into clinical development for the treatment of glaucoma and macular edema. This significant funding injection, led by prominent European venture capital…
Novel Eyeglass Lens Tech Offers Relief for Migraine Patients
This spring, individuals grappling with migraines find relieve with a novel solution for managing light sensitivity, thanks to new eyeglass lens technology developed by a physician-scientist at the University of Utah John A. Moran Eye Center. The Impact of Migraine…
Funding Boost for LambdaVision’s Artificial Retina
LambdaVision, a pioneering company dedicated to developing a protein-based artificial retina aimed at restoring sight lost to retinal degenerative diseases, announced the successful first closing of its seed round to advance its artificial retina development. The funding injection will fuel…